Clinical Trials Browser

Not yet recruiting × Recurrence × glofitamab × Clear all

NCT07453095 2026-03-05

Study With Glofitamab in Patients With MCL and Inadequate Response or Relapse Following CAR T-cell Therapy

Phase 2 Not yet recruiting

Recurrence, Lymphoma, Mantle-Cell